美國居民不適用 XM 服務。
S
S

Sacyr

交易方向

交易者脈動

技術摘要

小時

財經新聞

Sacyr posts 2% profit rise while seeking partner for growth

Sacyr posts 2% profit rise while seeking partner for growth MADRID, July 24 (Reuters) - Spanish engineering firm Sacyr reported on Wednesday a 2% increase in first-half net profit to 52 million euros ($56.38 million), largely in line with analysts' expectations. The company, which is focussed on motorway concessions and is seeking a partner to invest in larger and more profitable highways projects in the United States, said its revenues dipped 2% to 2.11 billion euros from the same period last y
S

Sacyr H1 Net Profit Up At 51.8 Mln Euros YoY

BRIEF-Sacyr H1 Net Profit Up At 51.8 Mln Euros YoY July 24 (Reuters) - Sacyr SA SCYR.MC : H1 NET PROFIT 51.8 MILLION EUROS VERSUS 50.5 MILLION EUROS YEAR AGO H1 EBITDA 657.2 MILLION EUROS VERSUS 628.9 MILLION EUROS YEAR AGO H1 NET SALES 2.12 BILLION EUROS VERSUS 2.16 BILLION EUROS YEAR AGO Source text for Eikon: ID:nCNMkcnrp Further company coverag
S

Sacyr seeks partner to compete for major US highway projects

Sacyr seeks partner to compete for major US highway projects By Corina Pons MADRID, July 15 (Reuters) - Spanish construction firm Sacyr SCYR.MC will hire financial advisors this month to help find a partner for new unit Voreantis as it seeks to raise cash and compete with larger rivals for lucrative infrastructure contracts in the United States. The motorway concession company plans to sell 49% of Voreantis , in which it has placed all its current assets, aiming to raise 800 million euros ($872
S

Sacyr-Ferrovial JV To Renew Torrevieja Desalination Plant For 89 Mln Euros

BRIEF-Sacyr-Ferrovial JV To Renew Torrevieja Desalination Plant For 89 Mln Euros July 4 (Reuters) - Sacyr SA SCYR.MC : IN JV WITH FERROVIAL TO RENEW TORREVIEJA DESALINATION PLANT FOR 89 MILLION EUROS CONTRACT INCLUDES OPERATION AND MAINTENANCE OF PLANT FOR FOUR YEARS Source text: https://tinyurl.com/r7yj37x9 Further company coverage: SCYR.MC (Gdans
S

4Imprint, AstraZeneca, Bellway

EUROPE RESEARCH ROUNDUP-4Imprint, AstraZeneca, Bellway June 5 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including 4Imprint, AstraZeneca and Bellway, on Wednesday. HIGHLIGHTS * 4Imprint FOUR.L : HSBC raises target price to 6370p from 6060p * AstraZeneca AZN.L : HSBC raises target price to 14070p from 12950p * Bellway Plc BWY.L : Berenberg raises target price to 2900p from 2500p * Berkeley Group BKGH.L : Berenberg raises target price to
A
A
B
B
B
B
B
C
E
G
G
H
H
I
M
M
O
P
R
R
S
B
E
M
N
P
R
S
T

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明